Home/Ironwood Pharmaceuticals/Thomas McCourt

TM

Thomas McCourt

Chief Executive Officer

Ironwood Pharmaceuticals

Roles

Chief Executive OfficeratIronwood Pharmaceuticals

Board MemberatPliant Therapeutics

Therapeutic Areas

Gastroenterology

Ironwood Pharmaceuticals Pipeline

Drug	Indication	Phase
LINZESS (linaclotide)	Irritable Bowel Syndrome with Constipation (IBS-C) & Chronic Idiopathic Constipation (CIC)	Marketed
Apraglutide	Short Bowel Syndrome with Intestinal Failure (SBS-IF)	Phase 3
CNP-104	Primary Biliary Cholangitis (PBC)	Preclinical

Leadership Team at Ironwood Pharmaceuticals

Michael Shetzline, M.D., Ph.D.

Senior Vice President, Chief Medical Officer and Head of Research and Development

View full Ironwood Pharmaceuticals profile